Status:
UNKNOWN
Postoperative Chronic Operation-related Symptoms After Minimally Invasive Lung Surgery
Lead Sponsor:
Fujian Medical University Union Hospital
Conditions:
Lung Cancer Stage I
Quality of Life
Eligibility:
All Genders
18+ years
Brief Summary
Lung cancer has been the most commonly diagnosed cancer globally over the past few decades. Histologically, adenocarcinoma in situ (AIS) and minimally invasive adenocarcinoma (MIA) are defined as canc...
Detailed Description
Lung cancer has been the most commonly diagnosed cancer globally over the past few decades. With the widespread use of Low-dose computedtomograph (LDCT), more and more lung nodules are being detected....
Eligibility Criteria
Inclusion
- Aged 18 years or above;
- Received single-port thoracoscopic surgery;
- Diagnosed with stage I lung cancer or benign lesions by histologic examination;
- Volunteered to participate in the study and signed an informed consent form.
Exclusion
- Previous thoracic surgery
- Any type of chronic pain, requiring daily use of analgetics
- Any type of chronic cough that requires daily medication
- pregnant
- Breast feeding
- contraindications to NSAID
- Combination of other tumors requiring chemotherapy or radiotherapy
Key Trial Info
Start Date :
August 18 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2024
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT06016881
Start Date
August 18 2023
End Date
December 1 2024
Last Update
November 18 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Maohui Chen
Fuzhou, Fujian, China, 350100